Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135,552 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022.
Su S, Chen Y, Zhang P, Ma R, Zhang W, Liu J, Li T, Niu H, Cao Y, Hu B, Gao J, Sun H, Fang D, Wang J, Wang PG, Xie S, Wang C, Ma J. Su S, et al. Among authors: liu j. Eur J Med Chem. 2022 Dec 5;243:114680. doi: 10.1016/j.ejmech.2022.114680. Epub 2022 Sep 12. Eur J Med Chem. 2022. PMID: 36152386 Review.
Polyamine-Based Pt(IV) Prodrugs as Substrates for Polyamine Transporters Preferentially Accumulate in Cancer Metastases as DNA and Polyamine Metabolism Dual-Targeted Antimetastatic Agents.
Liu H, Ma J, Li Y, Yue K, Li L, Xi Z, Zhang X, Liu J, Feng K, Ma Q, Liu S, Guo S, Wang PG, Wang C, Xie S. Liu H, et al. Among authors: liu j, liu s. J Med Chem. 2019 Dec 26;62(24):11324-11334. doi: 10.1021/acs.jmedchem.9b01641. Epub 2019 Dec 12. J Med Chem. 2019. PMID: 31765154
A Polyamine-Based Dinitro-Naphthalimide Conjugate as Substrates for Polyamine Transporters Preferentially Accumulates in Cancer Cells and Minimizes Side Effects in vitro and in vivo.
Ma J, Li Y, Li L, Yue K, Liu H, Wang J, Xi Z, Shi M, Zhao S, Ma Q, Liu S, Guo S, Liu J, Hou L, Wang C, Wang PG, Tian Z, Xie S. Ma J, et al. Among authors: liu j, liu h, liu s. Front Chem. 2020 Apr 9;8:166. doi: 10.3389/fchem.2020.00166. eCollection 2020. Front Chem. 2020. PMID: 32328475 Free PMC article.
Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II Trial.
Liu JF, Gaillard S, Wahner Hendrickson AE, Yeku O, Diver E, Gunderson Jackson C, Arend R, Ratner E, Samnotra V, Gupta D, Chung J, Zhang H, Compton N, Baines A, Bacqué E, Liu X, Felicetti B, Konecny GE. Liu JF, et al. JCO Precis Oncol. 2024 May;8:e2300693. doi: 10.1200/PO.23.00693. JCO Precis Oncol. 2024. PMID: 38754056 Clinical Trial.
Delocalized, asynchronous, closed-loop discovery of organic laser emitters.
Strieth-Kalthoff F, Hao H, Rathore V, Derasp J, Gaudin T, Angello NH, Seifrid M, Trushina E, Guy M, Liu J, Tang X, Mamada M, Wang W, Tsagaantsooj T, Lavigne C, Pollice R, Wu TC, Hotta K, Bodo L, Li S, Haddadnia M, Wołos A, Roszak R, Ser CT, Bozal-Ginesta C, Hickman RJ, Vestfrid J, Aguilar-Granda A, Klimareva EL, Sigerson RC, Hou W, Gahler D, Lach S, Warzybok A, Borodin O, Rohrbach S, Sanchez-Lengeling B, Adachi C, Grzybowski BA, Cronin L, Hein JE, Burke MD, Aspuru-Guzik A. Strieth-Kalthoff F, et al. Among authors: liu j. Science. 2024 May 17;384(6697):eadk9227. doi: 10.1126/science.adk9227. Epub 2024 May 17. Science. 2024. PMID: 38753786
135,552 results
You have reached the last available page of results. Please see the User Guide for more information.